Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide

Molecular Imaging and Biology

Volumn 11, Issue 6, 2009, Pages 424-433

  Wang, Wei ^a   Shao, Ruping ^a   Wu, Qingping ^a   Ke, Shi ^a   McMurray, John ^a   Lang Jr , Frederick F ^a   Charnsangavej, Chusilp ^a   Gelovani, Juri G ^a   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cyclic peptides; Gelatinases; Near infrared fluorescent imaging; Optical imaging

Indexed keywords

ALANYLTHREONYLALANYLHISTIDYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLASPARTIC ACID AMIDE; ALANYTHREONYLTHREONYLHISTIDYLTRYPTOPHYLGLYCYLPHENLALANYLTHREONYLLEUCYL BETA ALANYL; ALANYTHREONYLTHREONYLHISTIDYLTRYPTOPHYLGLYCYLPHENLALANYLTHREONYLLEUCYLASPARTIC ACID AMIDE; AMIDE; ASPARTIC ACID; C PEPTIDE; CASEIN; CYCLOPEPTIDE; GELATINASE; GELATINASE A; GELATINASE INHIBITOR; HISTIDYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLASPARTIC ACID AMIDE; HISTIDYLTRYPTOPHYLGLYCYLPHENYLAMIDE; LYSINE; LYSYLALANYLHISTIDYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLASPARTIC ACID AMIDE; LYSYLTHREONYLALANYLHISTIDYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLASPARTIC ACID AMIDE; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME INHIBITION; FLUORESCENCE IMAGING; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; NEAR INFRARED SPECTROSCOPY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STABILITY; PROTEIN TARGETING; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; CARBOCYANINES; CELL LINE, TUMOR; FLUORESCENT DYES; GELATINASES; GLIOMA; HUMANS; LUNG NEOPLASMS; MALE; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PEPTIDES, CYCLIC; PHYSICOCHEMICAL PROCESSES; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN STABILITY; SPECTROSCOPY, NEAR-INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70350292706     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0219-y     Document Type: Article

References (30)

1. Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: New technological advances that enable in vivo molecular imaging. Eur Radiol 13:195-208
2. Sokolov K, Follen M, Aaron J et al (2003) Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 63:1999-2004
3. Gurfinkel M, Ke S, Wen X et al (2003) Near-infrared fluorescence optical imaging and tomography. Dis Markers 19:107-121
4. Herschman HR (2004) Molecular imaging: A view from the inside. J Nucl Cardiol 11:210-214
5. Folli S, Westermann P, Braichotte D et al (1994) Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res 54:2643-2649
6. Ballou B, Fisher GW, Waggoner AS et al (1995) Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies. Cancer Immunol Immunother 41:257-263
7. Becker A, Hessenius C, Bhargava S et al (2000) Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumors. Ann N Y Acad Sci 921:275-278
8. Achilefu S, Dorshow RB, Bugaj JE et al (2000) Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol 35:479-485
9. Zaheer A, Lenkinski RE, Mahmood A et al (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19:1148-1154
10. Ke S, Wen X, Gurfinkel M et al (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63:7870-7875
11. Weissleder R, Tung CH, Mahmood U et al (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375-378
12. Chen X, Conti PS, Moats RA (2004) In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res 64:8009-8014
13. Wang W, Ke S, Wu Q et al (2004) Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging 3:343-351
14. Murray GI, Duncan ME, O'Neil P et al (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461-462
15. Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573
16. Karakiulakis G, Papanikolaou C, Jankovic SM et al (1997) Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 17:158-168
17. Brooks PC, Stromblad S, Sanders LC et al (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-693
18. Vu TH, Shipley JM, Bergers G et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422
19. Koivunen E, Arap W, Valtanen H et al (1999) Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 17:768-774
20. Oltenfreiter R, Staelens L, Kersemans V et al (2006) Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents. Appl Radiat Isot 64:677-685
21. Schafers M, Riemann B, Kopka K et al (2004) Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 109:2554-2559
22. Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743-748
23. Bremer C, Bredow S, Mahmood U et al (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model. Radiology 221:523-529
24. McIntyre JO, Matrisian LM (2003) Molecular imaging of proteolytic activity in cancer. J Cell Biochem 90:1087-1097
25. Kuhnast B, Bodenstein C, Haubner R et al (2004) Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. Nucl Med Biol 31:337-344
26. Pirila E, Maisi P, Salo T et al (2001) In vivo localization of gelatinases (MMP-2 and -9) by in situ zymography with a selective gelatinase inhibitor. Biochem Biophys Res Commun 287:766-774
27. Hidalgo M, Eckhardt SG (2001) Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93:178-193
28. Mook ORF, Van Overbeek C, Ackema EG et al (2003) In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin. J Histochem Cytochem 51:821-829
29. Puyraimond A, Fridman R, Lemesle M et al (2001) MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res 262:28-36
30. Upadhyay J, Shekarriz B, Nemeth JA et al (1999) Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res 5:4105-4110